Orion
Finnish company developing pharmaceuticals and diagnostic tests.
Launch date
Employees
Market cap
€6.5b
Enterprise valuation
€6.6b (Public information from Sep 2024)
Share price
€47.14 ORNBV.HE
Company register number 1999212-6
Espoo Uusimaa (HQ)
Financials
Estimates*
| EUR | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 1.1b | 1.0b | 1.3b | 1.2b | 1.4b | 1.5b | 1.7b |
| % growth | 3 % | (3 %) | 29 % | (11 %) | 21 % | 4 % | 11 % |
| EBITDA | 335m | 285m | 489m | 321m | 428m | 385m | 487m |
| % EBITDA margin | 31 % | 27 % | 36 % | 27 % | 30 % | 26 % | 29 % |
| Profit | 220m | 194m | 350m | 217m | 296m | 261m | 344m |
| % profit margin | 20 % | 19 % | 26 % | 18 % | 20 % | 17 % | 21 % |
| EV / revenue | 4.7x | 4.8x | 5.3x | 4.7x | 4.7x | 4.5x | 4.0x |
| EV / EBITDA | 15.2x | 17.6x | 14.4x | 17.5x | 15.7x | 17.5x | 13.7x |
| R&D budget | 123m | 118m | 136m | 127m | - | - | - |
| R&D % of revenue | 11 % | 11 % | 10 % | 11 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
$290m | Growth Equity non VC | ||
| Total Funding | - | ||
Related Content
Recent News about Orion
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Orion
Edit
ACQUISITION by Orion Mar 2017
ACQUISITION by Orion Jun 2022
ACQUISITION by Orion Mar 2017
